Global Flu Vaccine Market by Manufacturers, Countries, Type and Application, Forecast to 2022

GLO1518000
122 Pages
August 2017
Pharmaceuticals

Download Sample Get Discount

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Scope of the Report:

This report focuses on the Flu Vaccine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

CSL

GSK

Sanofi Pasteur

Mylan

AstraZeneca

Pfizer

Johnson & Johnson

Market Segment by Regions, regional analysis covers

North America (USA, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Columbia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Whole Virus Vaccines

Split Virus Vaccines

Subunit Vaccines

Live Attenuated Virus Vaccines

Market Segment by Applications, can be divided into

For Children (6 months to 3 years)

For Adults and Children over 3 years

There are 15 Chapters to deeply display the global Flu Vaccine market.

Chapter 1, to describe Flu Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Flu Vaccine, with sales, revenue, and price of Flu Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Flu Vaccine, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Flu Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 Flu Vaccine Introduction

1.2 Market Analysis by Type

1.2.1 Whole Virus Vaccines

1.2.2 Split Virus Vaccines

1.2.3 Subunit Vaccines

1.2.4 Live Attenuated Virus Vaccines

1.3 Market Analysis by Applications

1.3.1 For Children (6 months to 3 years)

1.3.2 For Adults and Children over 3 years

1.4 Market Analysis by Regions

1.4.1 North America (USA, Canada and Mexico)

1.4.1.1 USA Market States and Outlook (2012-2022)

1.4.1.2 Canada Market States and Outlook (2012-2022)

1.4.1.3 Mexico Market States and Outlook (2012-2022)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2012-2022)

1.4.2.2 France Market States and Outlook (2012-2022)

1.4.2.3 UK Market States and Outlook (2012-2022)

1.4.2.4 Russia Market States and Outlook (2012-2022)

1.4.2.5 Italy Market States and Outlook (2012-2022)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2012-2022)

1.4.3.2 Japan Market States and Outlook (2012-2022)

1.4.3.3 Korea Market States and Outlook (2012-2022)

1.4.3.4 India Market States and Outlook (2012-2022)

1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2012-2022)

1.4.4.2 Egypt Market States and Outlook (2012-2022)

1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)

1.4.4.4 South Africa Market States and Outlook (2012-2022)

1.4.4.5 Nigeria Market States and Outlook (2012-2022)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 CSL

2.1.1 Business Overview

2.1.2 Flu Vaccine Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 CSL Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 GSK

2.2.1 Business Overview

2.2.2 Flu Vaccine Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Sanofi Pasteur

2.3.1 Business Overview

2.3.2 Flu Vaccine Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 Sanofi Pasteur Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Mylan

2.4.1 Business Overview

2.4.2 Flu Vaccine Type and Applications

2.4.2.1 Type 1

2.4.2.2 Type 2

2.4.3 Mylan Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 AstraZeneca

2.5.1 Business Overview

2.5.2 Flu Vaccine Type and Applications

2.5.2.1 Type 1

2.5.2.2 Type 2

2.5.3 AstraZeneca Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Pfizer

2.6.1 Business Overview

2.6.2 Flu Vaccine Type and Applications

2.6.2.1 Type 1

2.6.2.2 Type 2

2.6.3 Pfizer Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Johnson & Johnson

2.7.1 Business Overview

2.7.2 Flu Vaccine Type and Applications

2.7.2.1 Type 1

2.7.2.2 Type 2

2.7.3 Johnson & Johnson Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Flu Vaccine Market Competition, by Manufacturer

3.1 Global Flu Vaccine Sales and Market Share by Manufacturer

3.2 Global Flu Vaccine Revenue and Market Share by Manufacturer

3.3 Market Concentration Rate

3.3.1 Top 3 Flu Vaccine Manufacturer Market Share

3.3.2 Top 6 Flu Vaccine Manufacturer Market Share

3.4 Market Competition Trend

4 Global Flu Vaccine Market Analysis by Regions

4.1 Global Flu Vaccine Sales, Revenue and Market Share by Regions

4.1.1 Global Flu Vaccine Sales by Regions (2012-2017)

4.1.2 Global Flu Vaccine Revenue by Regions (2012-2017)

4.2 North America Flu Vaccine Sales and Growth (2012-2017)

4.3 Europe Flu Vaccine Sales and Growth (2012-2017)

4.4 Asia-Pacific Flu Vaccine Sales and Growth (2012-2017)

4.5 South America Flu Vaccine Sales and Growth (2012-2017)

4.6 Middle East and Africa Flu Vaccine Sales and Growth (2012-2017)

5 North America Flu Vaccine by Countries

5.1 North America Flu Vaccine Sales, Revenue and Market Share by Countries

5.1.1 North America Flu Vaccine Sales by Countries (2012-2017)

5.1.2 North America Flu Vaccine Revenue by Countries (2012-2017)

5.2 USA Flu Vaccine Sales and Growth (2012-2017)

5.3 Canada Flu Vaccine Sales and Growth (2012-2017)

5.4 Mexico Flu Vaccine Sales and Growth (2012-2017)

6 Europe Flu Vaccine by Countries

6.1 Europe Flu Vaccine Sales, Revenue and Market Share by Countries

6.1.1 Europe Flu Vaccine Sales by Countries (2012-2017)

6.1.2 Europe Flu Vaccine Revenue by Countries (2012-2017)

6.2 Germany Flu Vaccine Sales and Growth (2012-2017)

6.3 UK Flu Vaccine Sales and Growth (2012-2017)

6.4 France Flu Vaccine Sales and Growth (2012-2017)

6.5 Russia Flu Vaccine Sales and Growth (2012-2017)

6.6 Italy Flu Vaccine Sales and Growth (2012-2017)

7 Asia-Pacific Flu Vaccine by Countries

7.1 Asia-Pacific Flu Vaccine Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Flu Vaccine Sales by Countries (2012-2017)

7.1.2 Asia-Pacific Flu Vaccine Revenue by Countries (2012-2017)

7.2 China Flu Vaccine Sales and Growth (2012-2017)

7.3 Japan Flu Vaccine Sales and Growth (2012-2017)

7.4 Korea Flu Vaccine Sales and Growth (2012-2017)

7.5 India Flu Vaccine Sales and Growth (2012-2017)

7.6 Southeast Asia Flu Vaccine Sales and Growth (2012-2017)

8 South America Flu Vaccine by Countries

8.1 South America Flu Vaccine Sales, Revenue and Market Share by Countries

8.1.1 South America Flu Vaccine Sales by Countries (2012-2017)

8.1.2 South America Flu Vaccine Revenue by Countries (2012-2017)

8.2 Brazil Flu Vaccine Sales and Growth (2012-2017)

8.3 Argentina Flu Vaccine Sales and Growth (2012-2017)

8.4 Columbia Flu Vaccine Sales and Growth (2012-2017)

9 Middle East and Africa Flu Vaccine by Countries

9.1 Middle East and Africa Flu Vaccine Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Flu Vaccine Sales by Countries (2012-2017)

9.1.2 Middle East and Africa Flu Vaccine Revenue by Countries (2012-2017)

9.2 Saudi Arabia Flu Vaccine Sales and Growth (2012-2017)

9.3 UAE Flu Vaccine Sales and Growth (2012-2017)

9.4 Egypt Flu Vaccine Sales and Growth (2012-2017)

9.5 Nigeria Flu Vaccine Sales and Growth (2012-2017)

9.6 South Africa Flu Vaccine Sales and Growth (2012-2017)

10 Global Flu Vaccine Market Segment by Type

10.1 Global Flu Vaccine Sales, Revenue and Market Share by Type (2012-2017)

10.1.1 Global Flu Vaccine Sales and Market Share by Type (2012-2017)

10.1.2 Global Flu Vaccine Revenue and Market Share by Type (2012-2017)

10.2 Whole Virus Vaccines Sales Growth and Price

10.2.1 Global Whole Virus Vaccines Sales Growth (2012-2017)

10.2.2 Global Whole Virus Vaccines Price (2012-2017)

10.3 Split Virus Vaccines Sales Growth and Price

10.3.1 Global Split Virus Vaccines Sales Growth (2012-2017)

10.3.2 Global Split Virus Vaccines Price (2012-2017)

10.4 Subunit Vaccines Sales Growth and Price

10.4.1 Global Subunit Vaccines Sales Growth (2012-2017)

10.4.2 Global Subunit Vaccines Price (2012-2017)

10.5 Live Attenuated Virus Vaccines Sales Growth and Price

10.5.1 Global Live Attenuated Virus Vaccines Sales Growth (2012-2017)

10.5.2 Global Live Attenuated Virus Vaccines Price (2012-2017)

11 Global Flu Vaccine Market Segment by Application

11.1 Global Flu Vaccine Sales Market Share by Application (2012-2017)

11.2 For Children (6 months to 3 years) Sales Growth (2012-2017)

11.3 For Adults and Children over 3 years Sales Growth (2012-2017)

12 Flu Vaccine Market Forecast (2017-2022)

12.1 Global Flu Vaccine Sales, Revenue and Growth Rate (2017-2022)

12.2 Flu Vaccine Market Forecast by Regions (2017-2022)

12.2.1 North America Flu Vaccine Market Forecast (2017-2022)

12.2.2 Europe Flu Vaccine Market Forecast (2017-2022)

12.2.3 Asia-Pacific Flu Vaccine Market Forecast (2017-2022)

12.2.4 South America Flu Vaccine Market Forecast (2017-2022)

12.2.5 Middle East and Africa Flu Vaccine Market Forecast (2017-2022)

12.3 Flu Vaccine Market Forecast by Type (2017-2022)

12.4 Flu Vaccine Market Forecast by Application (2017-2022)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Analyst Introduction

15.3 Data Source

List of Tables and Figures

Figure Flu Vaccine Picture

Table Product Specifications of Flu Vaccine

Figure Global Sales Market Share of Flu Vaccine by Types in 2016

Table Flu Vaccine Types for Major Manufacturers

Figure Whole Virus Vaccines Picture

Figure Split Virus Vaccines Picture

Figure Subunit Vaccines Picture

Figure Live Attenuated Virus Vaccines Picture

Table Flu Vaccine Sales Market Share by Applications in 2016

Figure For Children (6 months to 3 years) Picture

Figure For Adults and Children over 3 years Picture

Figure USA Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Figure Canada Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Figure Mexico Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Figure Germany Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Figure France Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Figure UK Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Figure Russia Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Figure Italy Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Figure China Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Figure Japan Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Figure Korea Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Figure India Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Figure Southeast Asia Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Figure Brazil Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Figure Egypt Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Figure Saudi Arabia Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Figure South Africa Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Figure Nigeria Flu Vaccine Revenue (Value) and Growth Rate (2012-2022)

Table CSL Basic Information, Manufacturing Base and Competitors

Table CSL Flu Vaccine Type and Applications

Table CSL Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GSK Basic Information, Manufacturing Base and Competitors

Table GSK Flu Vaccine Type and Applications

Table GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Pasteur Basic Information, Manufacturing Base and Competitors

Table Sanofi Pasteur Flu Vaccine Type and Applications

Table Sanofi Pasteur Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Flu Vaccine Type and Applications

Table Mylan Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Flu Vaccine Type and Applications

Table AstraZeneca Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Flu Vaccine Type and Applications

Table Pfizer Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Flu Vaccine Type and Applications

Table Johnson & Johnson Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Flu Vaccine Sales by Manufacturer (2016-2017)

Figure Global Flu Vaccine Sales Market Share by Manufacturer in 2016

Figure Global Flu Vaccine Sales Market Share by Manufacturer in 2017

Table Global Flu Vaccine Revenue by Manufacturer (2016-2017)

Figure Global Flu Vaccine Revenue Market Share by Manufacturer in 2016

Figure Global Flu Vaccine Revenue Market Share by Manufacturer in 2017

Figure Global Flu Vaccine Sales and Growth (2012-2017)

Figure Global Flu Vaccine Revenue and Growth (2012-2017)

Table Global Flu Vaccine Sales by Regions (2012-2017)

Table Global Flu Vaccine Sales Market Share by Regions (2012-2017)

Table Global Flu Vaccine Revenue by Regions (2012-2017)

Table Global Flu Vaccine Revenue Market Share by Regions in 2012

Table Global Flu Vaccine Revenue Market Share by Regions in 2016

Figure North America Flu Vaccine Sales and Growth (2012-2017)

Figure Europe Flu Vaccine Sales and Growth (2012-2017)

Figure Asia-Pacific Flu Vaccine Sales and Growth (2012-2017)

Figure South America Flu Vaccine Sales and Growth (2012-2017)

Figure Middle East and Africa Flu Vaccine Sales and Growth (2012-2017)

Figure North America Flu Vaccine Revenue and Growth (2012-2017)

Table North America Flu Vaccine Sales by Countries (2012-2017)

Table North America Flu Vaccine Sales Market Share by Countries (2012-2017)

Figure North America Flu Vaccine Sales Market Share by Countries in 2012

Figure North America Flu Vaccine Sales Market Share by Countries in 2016

Table North America Flu Vaccine Revenue by Countries (2012-2017)

Table North America Flu Vaccine Revenue Market Share by Countries (2012-2017)

Figure North America Flu Vaccine Revenue Market Share by Countries in 2012

Figure North America Flu Vaccine Revenue Market Share by Countries in 2016

Figure USA Flu Vaccine Sales and Growth (2012-2017)

Figure Canada Flu Vaccine Sales and Growth (2012-2017)

Figure Mexico Flu Vaccine Sales and Growth (2012-2017)

Figure Europe Flu Vaccine Revenue and Growth (2012-2017)

Table Europe Flu Vaccine Sales by Countries (2012-2017)

Table Europe Flu Vaccine Sales Market Share by Countries (2012-2017)

Table Europe Flu Vaccine Revenue by Countries (2012-2017)

Table Europe Flu Vaccine Revenue Market Share by Countries in 2012

Table Europe Flu Vaccine Revenue Market Share by Countries in 2016

Figure Germany Flu Vaccine Sales and Growth (2012-2017)

Figure UK Flu Vaccine Sales and Growth (2012-2017)

Figure France Flu Vaccine Sales and Growth (2012-2017)

Figure Russia Flu Vaccine Sales and Growth (2012-2017)

Figure Italy Flu Vaccine Sales and Growth (2012-2017)

Figure Asia-Pacific Flu Vaccine Revenue and Growth (2012-2017)

Table Asia-Pacific Flu Vaccine Sales by Countries (2012-2017)

Table Asia-Pacific Flu Vaccine Sales Market Share by Countries (2012-2017)

Table Asia-Pacific Flu Vaccine Revenue by Countries (2012-2017)

Table Asia-Pacific Flu Vaccine Revenue Market Share by Countries (2012-2017)

Figure China Flu Vaccine Sales and Growth (2012-2017)

Figure Japan Flu Vaccine Sales and Growth (2012-2017)

Figure Korea Flu Vaccine Sales and Growth (2012-2017)

Figure India Flu Vaccine Sales and Growth (2012-2017)

Figure Southeast Asia Flu Vaccine Sales and Growth (2012-2017)

Figure South America Flu Vaccine Revenue and Growth (2012-2017)

Table South America Flu Vaccine Sales by Countries (2012-2017)

Table South America Flu Vaccine Sales Market Share by Countries (2012-2017)

Figure South America Flu Vaccine Sales Market Share by Countries in 2016

Table South America Flu Vaccine Revenue by Countries (2012-2017)

Table South America Flu Vaccine Revenue Market Share by Countries (2012-2017)

Figure South America Flu Vaccine Revenue Market Share by Countries in 2012

Figure South America Flu Vaccine Revenue Market Share by Countries in 2016

Figure Brazil Flu Vaccine Sales and Growth (2012-2017)

Figure Argentina Flu Vaccine Sales and Growth (2012-2017)

Figure Columbia Flu Vaccine Sales and Growth (2012-2017)

Figure Middle East and Africa Flu Vaccine Revenue and Growth (2012-2017)

Table Middle East and Africa Flu Vaccine Sales by Countries (2012-2017)

Table Middle East and Africa Flu Vaccine Sales Market Share by Countries (2012-2017)

Figure Middle East and Africa Flu Vaccine Sales Market Share by Countries in 2016

Table Middle East and Africa Flu Vaccine Revenue by Countries (2012-2017)

Table Middle East and Africa Flu Vaccine Revenue Market Share by Countries (2012-2017)

Figure Middle East and Africa Flu Vaccine Revenue Market Share by Countries in 2012

Figure Middle East and Africa Flu Vaccine Revenue Market Share by Countries in 2016

Figure Saudi Arabia Flu Vaccine Sales and Growth (2012-2017)

Figure UAE Flu Vaccine Sales and Growth (2012-2017)

Figure Egypt Flu Vaccine Sales and Growth (2012-2017)

Figure Nigeria Flu Vaccine Sales and Growth (2012-2017)

Figure South Africa Flu Vaccine Sales and Growth (2012-2017)

Table Global Flu Vaccine Sales by Type (2012-2017)

Table Global Flu Vaccine Sales Share by Type (2012-2017)

Table Global Flu Vaccine Revenue by Type (2012-2017)

Table Global Flu Vaccine Revenue Share by Type (2012-2017)

Figure Global Whole Virus Vaccines Sales Growth (2012-2017)

Figure Global Whole Virus Vaccines Price (2012-2017)

Figure Global Split Virus Vaccines Sales Growth (2012-2017)

Figure Global Split Virus Vaccines Price (2012-2017)

Figure Global Subunit Vaccines Sales Growth (2012-2017)

Figure Global Subunit Vaccines Price (2012-2017)

Figure Global Live Attenuated Virus Vaccines Sales Growth (2012-2017)

Figure Global Live Attenuated Virus Vaccines Price (2012-2017)

Table Global Flu Vaccine Sales by Application (2012-2017)

Table Global Flu Vaccine Sales Share by Application (2012-2017)

Figure Global For Children (6 months to 3 years) Sales Growth (2012-2017)

Figure Global For Adults and Children over 3 years Sales Growth (2012-2017)

Figure Global Flu Vaccine Sales, Revenue and Growth Rate (2017 -2022)

Table Global Flu Vaccine Sales Forecast by Regions (2017-2022)

Table Global Flu Vaccine Market Share Forecast by Regions (2017-2022)

Figure North America Sales Flu Vaccine Market Forecast (2017-2022)

Figure Europe Sales Flu Vaccine Market Forecast (2017-2022)

Figure Asia-Pacific Sales Flu Vaccine Market Forecast (2017-2022)

Figure South America Sales Flu Vaccine Market Forecast (2017-2022)

Figure Middle East and Africa Sales Flu Vaccine Market Forecast (2017-2022)

Table Global Flu Vaccine Sales Forecast by Type (2017-2022)

Table Global Flu Vaccine Market Share Forecast by Type (2017-2022)

Table Global Flu Vaccine Sales Forecast by Application (2017-2022)

Table Global Flu Vaccine Market Share Forecast by Application (2017-2022)

Table Distributors/Traders/ Dealers List

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

Publish Date: November 14, 2017
$5370

View Details

Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

Publish Date: July 20, 2017
$5370

View Details

Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

Publish Date: April 24, 2017
$5370

View Details

Client Testimonials

Your team has worked hard to help and to provide our research needs to fulfill our significant initiatives...

Maria

-Researcher

The report on EAA resins was detailed and informative. However, we were hopeful to discover a Chinese producer ...

David

-President Protech Oxyplast Group

Thanks the attached report is perfect and accurate, but I was wondering if you can show the price trend in one year...

Global Flu Vaccine Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara